News and Announcements
Muoverti kickstarts its latest fundraising round with the lead investment from Ganash Invest B.V.
- Published August 18, 2022 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
“Muoverti’s TiltBike makes virtual indoor sessions feel like real rides. Clip in and conquer the
Metaverse.” – Men’s Health
“The idea of a much more integrated, much more realistic indoor experience touched all the right buttons for me. I think that adds together to be a very compelling proposition.” – David Stroud
Muoverti is a pioneering sports tech business, on a mission to build the world’s best at-home cycling experience for sport cyclists and multi-sport athletes. Unlike current options, TiltBikes feel more natural for the body – like riding a bike outdoors – and enable immersive simulations for essential training, esports, and interactive fitness. The TiltBike and its connected online applications enable new, immersive media experiences, from structured plans to e-sports and interactive gaming.
After enthusiastic public reception Muoverti now has 10x more people on the waitlist than they currently have capacity. Muoverti closed £1.64M Seed earlier this year and has just signed £500K of lead investment by Ganash Invest B.V., Amsterdam for this next fundraising round. The company is now looking to fill the additional headroom through convertibles that benefit from a 20% discount on the share price of the next round if signed by September 31st. Get in touch to join the ride!
Muoverti was founded by entrepreneurs Christoph Wilfert and Alex Caccia, also the original founder of WaterRower. Muoverti is based in London, UK.
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
